Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6Neoplasms 5Pain 4Sleep Initiation and Maintenance Disorders 3Prostatic Neoplasms 3Colorectal Neoplasms 3Vomiting 2Polycystic Ovary Syndrome 2Pancreatic Neoplasms 2Nausea 2Depression 2Carcinoma, Non-Small-Cell Lung 2Cancer Pain 2Anxiety Disorders 2Acupuncture 2Xerostomia 1Urinary Incontinence, Stress 1Urinary Incontinence 1Sarcoma, Ewing 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Radiation Injuries 1Prostatic Hyperplasia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Urinary Retention (POUR) 1Postoperative Nausea and Vomiting 1Postoperative Ileus 1Postoperative Complications 1PGS 1Osteosarcoma 1

Interventions

Cognitive Training 2Tobacco Use Cessation Devices 1Sodium Chloride 1Saline Solution 1Palliative Care 1Neuroprotective Agents 1Mesna 1Magnetic Resonance Spectroscopy 1High-Intensity Interval Training 1Functional Status 1Electroacupuncture 1Drug Therapy 1Doxorubicin 1Cyclophosphamide 1Ashwagandha 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Chemotherapy-Related Cognitive Impairment × Electroacupuncture × Clear all
NCT05941598 2023-07-14

Electroacupuncture for Chemotherapy-Related Cognitive Impairment

Beijing University of Chinese Medicine

Phase 2 Unknown
100 enrolled

Chemotherapy-Related Cognitive Impairment

Data powered by HemOnc (CC BY 4.0) Colophon âš¡